Serina Therapeutics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Serina Therapeutics, Inc. (SER) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- Serina Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.05M, a 18.09% increase year-over-year.
- Serina Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.08M, a 12.66% increase year-over-year.
- Serina Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $999.00K, a 8.85% decline year-over-year.
- Serina Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $890.00K, a 94.32% increase year-over-year.
- Serina Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $3.79M, a 46.17% increase from fiscal 2024.
- Serina Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $2.60M, a 10280.00% increase from fiscal 2023.
- Serina Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $25.00K, a 96.71% decline from fiscal 2022.
- Serina Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $760.00K, a 24.23% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.05M 10-Q · filed 2026-08-13 | $2.13M derived: sum of 2 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | $1.08M 10-Q · filed 2026-08-13 | ||||||
| 2025-12-31 | $3.79M 10-K · filed 2026-03-25 | ||||||
| 2025-09-30 | $999.00K 10-Q · filed 2025-11-13 | $1.89M derived: sum of 2 quarters · filed 2026-08-13 | $2.85M derived: sum of 3 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $890.00K 10-Q · filed 2026-08-13 | $1.85M derived: sum of 2 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $956.00K 10-Q · filed 2026-08-13 | ||||||
| 2024-12-31 | $2.60M 10-K · filed 2026-03-25 | ||||||
| 2024-09-30 | $1.10M 10-Q · filed 2025-11-13 | $1.55M derived: sum of 2 quarters · filed 2025-11-13 | $1.61M derived: sum of 3 quarters · filed 2025-11-13 | $1.49M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $458.00K 10-Q · filed 2025-11-13 | $511.00K 10-Q · filed 2024-08-09 | $391.00K derived: sum of 3 quarters · filed 2025-11-13 | $431.00K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-03-31 | $53.00K 10-Q · filed 2025-11-13 | -$67.00K derived: sum of 2 quarters · filed 2025-11-13 | -$27.00K derived: sum of 3 quarters · filed 2025-11-13 | -$4.00K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2023-12-31 | -$120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$80.00K derived: sum of 2 quarters · filed 2025-03-24 | -$57.00K derived: sum of 3 quarters · filed 2025-03-24 | $25.00K 10-K · filed 2025-03-24 | $648.00K 10-K · filed 2024-03-22 | ||
| 2023-09-30 | $40.00K 10-Q · filed 2023-11-14 | $63.00K derived: sum of 2 quarters · filed 2024-11-12 | $145.00K 10-Q · filed 2023-11-14 | $179.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $23.00K 10-Q · filed 2024-11-12 | $35.00K 10-Q · filed 2023-08-14 | $25.00K 10-Q · filed 2024-08-09 | $105.00K 10-Q · filed 2023-08-14 | $139.00K derived: sum of 3 quarters · filed 2024-11-12 | $348.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-03-31 | $2.00K 10-Q · filed 2024-11-12 | $70.00K 10-Q · filed 2023-05-12 | $116.00K derived: sum of 2 quarters · filed 2024-11-12 | $325.00K derived: sum of 3 quarters · filed 2024-11-12 | $523.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2022-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $323.00K derived: sum of 2 quarters · filed 2024-03-22 | $521.00K derived: sum of 3 quarters · filed 2024-03-22 | $760.00K 10-K · filed 2024-03-22 | |||
| 2022-09-30 | $209.00K 10-Q · filed 2023-11-14 | $407.00K derived: sum of 2 quarters · filed 2023-11-14 | $646.00K 10-Q · filed 2023-11-14 | $909.00K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $198.00K 10-Q · filed 2023-08-14 | $437.00K 10-Q · filed 2023-08-14 | $700.00K derived: sum of 3 quarters · filed 2023-08-14 | $972.00K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $239.00K 10-Q · filed 2023-05-12 | $502.00K derived: sum of 2 quarters · filed 2023-05-12 | $774.00K derived: sum of 3 quarters · filed 2023-05-12 | $1.06M derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $535.00K derived: sum of 2 quarters · filed 2023-03-31 | $821.00K derived: sum of 3 quarters · filed 2023-03-31 | $1.00M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $272.00K 10-Q · filed 2022-11-10 | $558.00K derived: sum of 2 quarters · filed 2022-11-10 | $740.00K 10-Q · filed 2022-11-10 | $922.00K derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $286.00K 10-Q · filed 2022-08-12 | $468.00K 10-Q · filed 2022-08-12 | $650.00K derived: sum of 3 quarters · filed 2022-08-12 | $882.00K derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $182.00K 10-Q · filed 2022-05-13 | $364.00K derived: sum of 2 quarters · filed 2022-05-13 | $596.00K derived: sum of 3 quarters · filed 2022-05-13 | $855.00K derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $414.00K derived: sum of 2 quarters · filed 2022-03-29 | $673.00K derived: sum of 3 quarters · filed 2022-03-29 | $933.00K 10-K · filed 2022-03-29 | |||
| 2020-09-30 | $232.00K 10-Q · filed 2021-11-12 | $491.00K derived: sum of 2 quarters · filed 2021-11-12 | $751.00K 10-Q · filed 2021-11-12 | $1.17M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $259.00K 10-Q · filed 2021-08-13 | $519.00K 10-Q · filed 2021-08-13 | $939.00K derived: sum of 3 quarters · filed 2021-08-13 | $1.43M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $260.00K 10-Q · filed 2021-05-17 | $680.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.17M derived: sum of 3 quarters · filed 2021-05-17 | $1.69M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $911.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.43M derived: sum of 3 quarters · filed 2021-03-31 | $1.91M 10-K · filed 2021-03-31 | |||
| 2019-09-30 | $491.00K 10-Q · filed 2020-11-16 | $1.01M derived: sum of 2 quarters · filed 2020-11-16 | $1.49M 10-Q · filed 2020-11-16 | $2.28M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | $515.00K 10-Q · filed 2020-08-14 | $996.00K 10-Q · filed 2020-08-14 | $96.00K 10-Q · filed 2019-08-14 | $1.79M derived: sum of 3 quarters · filed 2020-08-14 | $1.97M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $481.00K 10-Q · filed 2020-05-14 | $1.28M derived: sum of 2 quarters · filed 2020-05-14 | $1.45M derived: sum of 3 quarters · filed 2020-05-14 | $1.62M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | $797.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | $973.00K derived: sum of 2 quarters · filed 2020-03-31 | $1.14M derived: sum of 3 quarters · filed 2020-03-31 | $1.28M 10-K/A · filed 2020-03-31 | |||
| 2018-09-30 | $176.00K 10-Q · filed 2019-11-14 | $343.00K derived: sum of 2 quarters · filed 2019-11-14 | $488.00K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | $167.00K 10-Q · filed 2019-08-14 | $312.00K 10-Q · filed 2019-08-14 | |||||
| 2018-03-31 | $145.00K 10-Q · filed 2019-05-15 | ||||||
| 2017-12-31 | $114.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |